AAAAAA
Results:
1-10
|
Results: 10
Authors:
Gion, M
Mione, R
Leon, AE
Luftner, D
Molina, R
Possinger, K
Robertson, JF
Citation: M. Gion et al., CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases, EUR J CANC, 37(3), 2001, pp. 355-363
Authors:
Luftner, D
Bollow, M
Sturzenbecher, A
Kaufmann, O
Priem, F
Richter, A
Gunther, S
Geppert, R
Petrides, PE
Wernecke, KD
Possinger, K
Citation: D. Luftner et al., Biomarkers and imaging in non-malignant and malignant osteomalacia, INT J B MAR, 16(2), 2001, pp. 136-141
Authors:
Olver, I
Davy, M
Luftner, D
Park, SH
Egorin, M
Ellis, A
Webster, L
Citation: I. Olver et al., A phase I study of paclitaxel and altretamine as second-line therapy to cisplatin regimens for ovarian cancer, CANC CHEMOT, 48(2), 2001, pp. 109-114
Authors:
Cook, GB
Neaman, IE
Goldblatt, JL
Cambetas, DR
Hussain, M
Luftner, D
Yeung, KK
Chan, DW
Schwartz, MK
Allard, WJ
Citation: Gb. Cook et al., Clinical utility of scram HER-2/neu testing on the Bayer Immuno 1 (R) automated system in breast cancer, ANTICANC R, 21(2B), 2001, pp. 1465-1470
Authors:
Sezer, O
Eucker, J
Bauhuis, C
Schweigert, M
Luftner, D
Kalus, U
Spath-Schwalbe, E
Arnold, R
Possinger, K
Citation: O. Sezer et al., Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantation, ANN HEMATOL, 79(11), 2000, pp. 627-630
Authors:
Luftner, D
Mesterharm, J
Akrivakis, C
Geppert, R
Petrides, PE
Wernecke, KD
Possinger, K
Citation: D. Luftner et al., Tumor type M2 pyruvate kinase expression in advanced breast cancer, ANTICANC R, 20(6D), 2000, pp. 5077-5082
Authors:
Luftner, D
Flath, B
Akrivakis, C
Prinz, B
Mergenthaler, HG
Wernecke, KD
Possinger, K
Citation: D. Luftner et al., Feasibility of dose-intensified paclitaxel after chemotherapy-induced renal insufficiency in a patient with renal transplantation, EUR J CANC, 35(2), 1999, pp. 325-325
Authors:
Luftner, D
Wagner, K
Dingeldein, G
Haas, A
Sezer, O
Mergenthaler, HG
Wernecke, KD
Possinger, K
Citation: D. Luftner et al., Adjuvant high-dose chemotherapy with epirubicin and ifosfamide in nodal positive breast cancer, ANTICANC R, 19(4C), 1999, pp. 3583-3590
Authors:
Luftner, D
Gunther, S
Flath, B
Muller, C
Echteroff, K
Mergenthaler, HG
Wernecke, KD
Possinger, K
Citation: D. Luftner et al., The course of the urinary DPD-crosslink secretion in metastatic breast cancer - A possibility for response assessment, ANTICANC R, 19(4A), 1999, pp. 2537-2544
Authors:
Luftner, D
Prinz, B
Possinger, K
Citation: D. Luftner et al., Evaluation of the quality of life of breast cancer patients, GEBURTSH FR, 58(12), 1998, pp. M190-M193
Risultati:
1-10
|